[Hematuria due to increased urokinase activity. Its successful treatment with p-aminomethylbenzoic acid (PAMBA)].
D000328:Adult; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D005342:Fibrinolysis; D006417:Hematuria / Q000209:etiology*; D006801:Humans; D008875:Middle Aged
D000933:Antifibrinolytic Agents; D001565:Benzoates
Hämaturie infolge gesteigerter Urokinase-Aktivität. Ihre erfolgreiche Behandlung durch p-aminomethylbenzoesäure (PAMBA)